SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma: While mouse models are indispensable for better understanding basic mechanisms of inflammation and cancer, only clinical trials will be able to assess whether individual JAK or STAT alterations have a role in CTCL pathogenesis.